Denshisha Co., Ltd. Introduces Urine Cancer Risk Test 'My Signal Scan' as Employee Benefit
NQ Score
79/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Craif Inc. announced that Denshisha Co., Ltd. has introduced the urine cancer risk test 'My Signal Scan' as a welfare benefit. Denshisha covers all employees and their spouses, with full cost coverage, and approximately 93% of eligible persons applied for the test.
AI Analysis
Frequently Asked Questions
- Q: What cancers does My Signal Scan test for?
- A: 10 types including pancreatic cancer. Ovarian/breast cancer for women, prostate for men.
- Q: How much does the test cost?
- A: In Denshisha's case, fully covered by the company. Check official site for general pricing.
- Q: How are results delivered?
- A: Results are available via app or web. Contact provider for details.